Immunology, Microbiology & IBD

Dear Member of the Immunology, Microbiology & Inflammatory Bowel Diseases Section and interested others:

We thank you for attending the 41st annual DDW® in New Orleans, LA and making it a scientifically relevant and exciting meeting! If you have specific feedback regarding speakers sponsored by the Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section at DDW, please share your thoughts with us. We will do our best to consider your comments and concerns as we plan our program for next DDW 2011 in Chicago.

One of our section's abstracts "The Crohn's Disease protective SNP rs11209026 allele "A" mediates alternative splicing in human IL23R transcription." was presented at the successful AGA Institute Basic Science Plenary Session.

We would like to welcome the newly elected Immunology, Microbiology & Inflammatory Bowel Diseases Section Vice-Chair, Maria T. Abreu, MD. And the newly elected Nominating Committee Members: David T. Rubin, MD, AGAF; Uma Mahadevan , MD; Jean Frederick Colombel, MD; and Gert Van Assche, MD, PhD. We would also like to thank R. Balfour Sartor, MD for his invaluable service as Chair of the Immunology, Microbiology & Inflammatory Bowel Diseases Section from 2008-2010. Thank you to all those who participated in the election and voted.

This year the IMIBD section accepted the majority of the abstracts submitted. The accepted abstracts were designated as oral or poster presentations and of distinction based on their ranking by our dedicated abstract reviewers.

IMIBD Abstract Selection 2010
Total Abstracts submitted 911
Accepted Abstracts 692
Oral Presentations 127
Posters 565
Posters of Distinction 68

IMIBD sponsored Clinical, Translational, and Research Symposia, and abstract based Research and Topic Fora.

IMIBD Sessions
Sunday, May 2, 2010 Attendance
Topic Forum: Microbial Composition and Pathogenic Mechanisms in Intestinal Inflammation and IBS 8:30am-10:00am 65
Research Forum: IBD Genetics 8:30am-10:00am 100
Cross-Sectional Topic Forum: Pediatric Gastroenterology: IBD and Inflammation 10:30am-12:00pm 150
Research Forum: Animal Models: Mechanisms of Intestinal Inflammation 10:30am-12:00pm 150
Research Forum: Environmental Risk Factors for IBD 10:30am-12:00pm 300
Research Symposia: Dietary Effects on Enteric Bacterial Composition and Gene Expression 2:15pm-3:45pm 200
Research Forum: Novel Laboratory Diagnostics in IBD 2:15pm-3:45pm 210
Cross-Sectional Topic Forum: Prebiotics and Probiotics in the Intestine: Activities and Function 4:00pm-5:30pm 150
Research Forum: IBD and Cancer 4:00pm-5:30pm 150
Monday, May 3, 2010
Research Forum: Mediation and Regulation of Intestinal Inflammation by Cytokines 2:15pm-3:45pm 275
Research Forum: Outcomes and Adverse Events Related to Treatment of IBD 2:15pm-3:45pm 650
Clinical Symposia: Anti-TNF Antibodies for IBD at 10 Years: A Clinician's Guide 4:00pm-5:30pm unknown
Research Forum: Surgery in IBD 4:00pm-5:30pm 140
Tuesday, May 4, 2010
Research Forum: Microbial/Host Interactions 8:30am-10:00am 82
Research Forum: Endoscopy and Imaging in IBD 8:30am-10:00am 300
Translational Symposia: Translating the New IBD Genetics into Therapy 8:30am-10:00am 300
Research Symposia: Novel Cytokine Signaling Pathways in IBD 10:30am-12:00pm 175
Research Forum: Clinical Trials in IBD 10:30am-12:00pm 2000
Research Forum: Bacterial-induced Immune Responses and Signaling 10:30am-12:00pm 110
Cross-Sectional Topic Forum: Stem Cell Biology 2:15pm-3:45pm 130
Research Forum: Mucosal Immunoregulation and Immune-Mediated Inflammation 2:15pm-3:45pm 200
Research Forum: Natural History and Outcomes of IBD 2:15pm-3:45pm 250
Immunology, Microbiology and Inflammatory Bowel Diseases Distinguished Abstract Plenary 4:00pm-5:30pm 600
Immunology, Microbiology and Inflammatory Bowel Diseases Section Business Meeting 5:30pm-6:30pm unknown
Wednesday, May 5, 2010
Clinical Symposia: Do No Harm? Risk and the Management of IBD 8:30am-10:00am 400
Research Forum: Immune Activation and Regulation in Intestinal Inflammation 8:30am-10:00am 100
Research Forum: Mucosal Innate Immune Function and Innate Host Defense 10:30am-12:00pm 90
Research Forum: Infections in IBD 10:30am-12:00pm 250
Research Forum: Preclinical Treatment of Intestinal Inflammation in Animal Models 2:15pm-3:45pm 70

Each June, IMIBD section descriptors are reviewed to optimize scientific relevance and minimize overlapping topics with other AGA Institute Sections and to encourage both clinical research and basic science abstract submissions. The current list of abstract descriptors is as follows. (IMIBD descriptors may change as we go forward to DDW 2011.) We would like to thank our abstract review Committee Chairs and members for generously sharing their expertise and time in order to ensure that the most novel and relevant developments in Immunology, Microbiology & Inflammatory Bowel Diseases were shared at DDW.

Descriptor Name Abstracts Received Abstract Review Chair Abstract Reviewers
IBD: Diagnostics in IBD 40 Willem de Villiers Jonathan Leighton, Iris Dotan, Laurent Peyrin-Biroulet
IBD: Disease Activity Assessment 32 Peter Higgins Thomas Ullman, Simon Travis, Anne Griffiths
IBD: Disease Complications and Outcomes 100 Hillary Steinhart Laurent Beaugerie, Miguel Regueiro, Remo Panaccione
IBD: Adverse Events Related to Therapy 30 Charles Bernstein David Rubin, Corey Siegel, Daniel Baumgart
IBD: Epidemiology and Natural History 82 Athos Bousvaros Michael Kapelman, Gil Kaplan, Geoffrey Nguyen
IBD: Uncontrolled Therapeutic Observations in Humans 83 Joshua Korzenik Gil Melmed, Ashwin Ananthakrishnan, Fernando Velayos
IBD: Controlled Clinical Trials in Humans 35 William Sandborn Marc Lemann, Geert van Assche, Hans Herfarth
IBD: Genetics 57 Judy Cho Vito Annese, Mark Silverberg
IBD: Immune Activation and Regulation 57 Giovanni Monteleone Takanori Kanai, Stefan Schreiber, Claudio Fiocchi
IBD: Therapeutic Monitoring 29 Uma Mahadevan Geert D'Haens, Jean-Frederic Colombel, Sunanda Kane
Animal Models: Mechanisms of Intestinal Inflammation 68 Lee Denson Paul Beck, Matthew B. Grisham, Atsushi Mizoguchi
Animal Models: Pre-Clinical Treatment of Intestinal Inflammation 50 Pawel R. Kiela John Wallace, Jesus Rivera-Nieves, David E. Elliott
Epithelial Cell Immune Function and Interactions with Immune Cells and Microbial Agents 31 Kim Barrett Elke Cario, Richard Blumberg, Gerhard Rogler
IBD: Non-immune Cell Function, Activation and Regulation 28 Barry K. Wershil Jay Kuemmerle, Ellen Zimmerman
IBD: Cytokines, Signaling and Receptors 45 Scott Snapper Christian Jobin, David L. Boone, Hans-Christian Reinecker
Mucosal Innate Immune Function and Innate Host Defense 38 Averil Ma Maria Abreu, Scott Plevy
Mucosal Lymphocyte Function and Regulation: Animal Models and in Vitro Studies 12 Mamoru Watanabe Monica Boirivant, Clara Abraham, Fabio Comivelli
Microbial-Induced Mucosal Inflammation and Immunity 59 Jon Braun Sarkis K. Mazmanian, Charles O. Elson, Ingo Autenrieth
Prebiotics and Probiotics (Cross-section descriptor) 17 Karen Madsen Andrew Gewirtz, Elena Verdu, Martin Floch
Pediatric IBD: Clinical and Translational Studies (Cross-section descriptor) 12 Francisco Sylvester Sandra Kim, Subra Kugathasan
Stem Cell Biology (Cross-section descriptor) 6 Michael Choi Steve Cohn, Bart Rountree, Tim Wang, Courtney Houchen

Section leaders will review committee membership this summer for abstract review committees to confirm the final composition for DDW 2011 committees.

IMIBD section members interested in serving in this capacity are encouraged to contact us and volunteer to review abstracts.

Please submit your invaluable ideas about the topics and invited speakers that you would like to hear at next year's DDW. The more specific you can be, the better (title, individual talks, speakers, learning objectives). Please forward your suggestions to John Whiton, AGA Institute by July 6, 2010.

Members interested in participating in the various activities of the Section should contact us at the addresses below. We are particularly interested in increasing participation by junior investigators/clinicians and international members at this time.

If you are interested in serving as a reviewer for any of our abstract descriptors, please let us know. Please cite the abstract descriptor for which you would be interested in reviewing. Please recommend any new descriptors for abstracts.

Thank you for your continuing strong support of the Immunology, Microbiology & Inflammatory Bowel Diseases Section.

Sincerely,

Bruce E. Sands, MD, MS, AGAF
Chair, IMIBD Section, AGA Institute Council

Maria T. Abreu, MD
Vice-Chair, IMIBD Section, AGA Institute Council